2026 NPPES data Hematology & Oncology Physician NPI 1750517785 MD
Verify on CMS →

PREETI SUDHEENDRA, MD

Hematology & Oncology Physician in CAMDEN, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
352
Medicare Part D claims · 103 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
95.311/100
▲ 12 pts above national avg 83.1 · [object Object]

What the federal data shows

PREETI SUDHEENDRA, MD reported a CMS MIPS final score of 95.311/100 — above the 83.1 national average — and filed 352 Medicare Part D claims in 2023.

95.311/100
MIPS score · +12 vs avg
352
Part D claims, 2023
84%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PREETI SUDHEENDRA, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

95 Top 21% higher than 79% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

PREETI SUDHEENDRA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PREETI SUDHEENDRA, MD?

High performer (top quartile)

NPI registry status

Active

Issued 06/04/2009

NPI 1750517785

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

352 58% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

95.311/100 12.211000000000013% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Jersey

How Hematology & Oncology Physician compares to other specialties among New Jersey providers

New Jersey providers

Hematology & Oncology Physician share within New Jersey

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New Jersey

Medicare quality performance — MIPS

PREETI SUDHEENDRA, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
95.311/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 95.311/100 vs national avg 83.1

0%100%National avg83%95.3%
MIPS final score (Hematology & Oncology Physician) — 95.311/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PREETI SUDHEENDRA, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 3 COOPER PLZ, CAMDEN, NJ, 08103, with a listed phone of (855) 632-2667. NPI 1750517785 was issued on 06/04/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SUDHEENDRA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 352 prescription claims written by this provider, covering 103 Medicare beneficiaries and totaling roughly $565K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 5.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.311/100 for the 2023 performance year (Quality 76.5856), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3 COOPER PLZ
CAMDEN, NJ 08103

Provider Details

NPI 1750517785
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 06/04/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

95.311
Final Score
Avg: 83.1
76.5856
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Brand vs generic prescribing mix · Typical

PREETI SUDHEENDRA, MD — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 352 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

352
Total Claims
$565K
Total Drug Cost
103
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
698
Total Day Supply
20,137
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$489K
Generic Drug Cost
$76K
Opioid Claims
19 (5.4% rate)

Patient Demographics

Average Patient Age
71.0 years
Avg HCC Risk Score
1.70

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What PREETI SUDHEENDRA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
80
Letrozole
45
Eliquis
Apixaban
18
Ibrance
Palbociclib
17
Duloxetine Hcl
15
Gabapentin
13
Exemestane
11
Tamoxifen Citrate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How PREETI SUDHEENDRA, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

PREETI SUDHEENDRA, MD's 352 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as SUDHEENDRA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PREETI SUDHEENDRA, MD's specialty?
PREETI SUDHEENDRA, MD specializes in Hematology & Oncology Physician and practices in CAMDEN, New Jersey. Credentials: MD.
How much does PREETI SUDHEENDRA, MD prescribe under Medicare Part D?
In 2023, PREETI SUDHEENDRA, MD wrote 352 Medicare Part D claims totaling $565K in drug costs for 103 beneficiaries.
What is PREETI SUDHEENDRA, MD's Medicare quality score?
PREETI SUDHEENDRA, MD has a CMS MIPS Final Score of 95.311/100 (Quality: 76.5856). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is PREETI SUDHEENDRA, MD located?
PREETI SUDHEENDRA, MD is located at 3 COOPER PLZ, CAMDEN, NJ, 08103. Phone: (855) 632-2667.
What is PREETI SUDHEENDRA, MD's NPI number?
PREETI SUDHEENDRA, MD's National Provider Identifier (NPI) is 1750517785, issued on 06/04/2009.
Does PREETI SUDHEENDRA, MD prescribe more brand-name or generic drugs?
PREETI SUDHEENDRA, MD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $489K in brand drug costs.
Does PREETI SUDHEENDRA, MD prescribe opioids?
Yes, PREETI SUDHEENDRA, MD had 19 opioid claims in 2023 with an opioid prescribing rate of 5.4%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does PREETI SUDHEENDRA, MD prescribe most often?
Based on 2023 Medicare Part D data, PREETI SUDHEENDRA, MD's most frequently prescribed drugs include Anastrozole, Letrozole, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PREETI SUDHEENDRA, MD accept Medicare?
PREETI SUDHEENDRA, MD appears in CMS Medicare data with 352 Part D claims and 103 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PREETI SUDHEENDRA, MD's credentials?
PREETI SUDHEENDRA, MD's NPI is 1750517785 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology